Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Johnson

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|January 1, 2013
Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor developmentDaniel T Johnson, Richard Luong, Suk Hyung Lee, et al.
Science (New York, N.Y.)|March 31, 2018
Destabilizing mutations encode nongenetic variation that drives evolutionary innovationKatherine L Petrie, Nathan D Palmer, Daniel T Johnson, et al.
Leukemia|November 30, 2021
Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapyDaniel T Johnson, Jiarong Zhou, Ashley V Kroll, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 15, 2025
Hemodynamic response of the aortic valve during dobutamine onset then progressive aortic bandingRob Eerdekens, Philipos K Gebremedhin, Daniel T Johnson, et al.
JACC. Cardiovascular Interventions|July 25, 2015
Repeatability of Fractional Flow Reserve Despite Variations in Systemic and Coronary HemodynamicsNils P Johnson, Daniel T Johnson, Richard L Kirkeeide, et al.
Blood|August 23, 2019
Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activationSamuel A Stoner, Ming Yan, Katherine Tin Heng Liu, et al.
The Journal of Biological Chemistry|November 8, 2018
Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostateJiaqi Mi, Erika Hooker, Steven Balog, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 2, 2022
Use of a Pressure Wire for Automatically Correcting Artifacts in Phasic Pressure Tracings From a Fluid-Filled CatheterDaniel T Johnson, Johan Svanerud, Jung-Min Ahn, et al.
Blood|September 5, 2021
Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemiaAmanda G Davis, Daniel T Johnson, Dinghai Zheng, et al.
Oncogene|July 31, 2019
Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostateYongfeng He, Daniel T Johnson, Julie S Yang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|January 1, 2013
Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor developmentDaniel T Johnson, Richard Luong, Suk Hyung Lee, et al.
Science (New York, N.Y.)|March 31, 2018
Destabilizing mutations encode nongenetic variation that drives evolutionary innovationKatherine L Petrie, Nathan D Palmer, Daniel T Johnson, et al.
Leukemia|November 30, 2021
Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapyDaniel T Johnson, Jiarong Zhou, Ashley V Kroll, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 15, 2025
Hemodynamic response of the aortic valve during dobutamine onset then progressive aortic bandingRob Eerdekens, Philipos K Gebremedhin, Daniel T Johnson, et al.
JACC. Cardiovascular Interventions|July 25, 2015
Repeatability of Fractional Flow Reserve Despite Variations in Systemic and Coronary HemodynamicsNils P Johnson, Daniel T Johnson, Richard L Kirkeeide, et al.
Blood|August 23, 2019
Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activationSamuel A Stoner, Ming Yan, Katherine Tin Heng Liu, et al.
The Journal of Biological Chemistry|November 8, 2018
Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostateJiaqi Mi, Erika Hooker, Steven Balog, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 2, 2022
Use of a Pressure Wire for Automatically Correcting Artifacts in Phasic Pressure Tracings From a Fluid-Filled CatheterDaniel T Johnson, Johan Svanerud, Jung-Min Ahn, et al.
Blood|September 5, 2021
Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemiaAmanda G Davis, Daniel T Johnson, Dinghai Zheng, et al.
Oncogene|July 31, 2019
Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostateYongfeng He, Daniel T Johnson, Julie S Yang, et al.
Pageof 3